Isoxsuprine Intravenous Drip Dosage
The FDA-approved oral dosage for isoxsuprine is 10 to 20 mg three or four times daily, but there is no established FDA-approved intravenous drip dosage for this medication. 1
Critical Context and Clinical Use
The evidence base reveals that isoxsuprine has been used off-label as an intravenous tocolytic agent in obstetric practice, though this represents non-FDA-approved use:
Reported IV Dosing Regimens in Research Literature
For tocolysis (preterm labor management):
- Initial IV infusion: 40 mg isoxsuprine hydrochloride administered intravenously until uterine quiescence is achieved 2
- Alternative regimen: 50 mg in 250 mL of D5W (dextrose 5% in water), with dosing titrated to effect 3
- Higher-dose regimen: 150-200 mcg/minute (9-12 mg/hour) administered as continuous IV infusion 4, 5
- Standard tocolytic dose: 30 mg administered intravenously over 30 minutes (1 mg/minute) 6
Important Safety Considerations
Contraindications that must be respected:
Monitoring requirements based on research data:
- Maternal tachycardia is common (8% incidence) and may require dose adjustment 2
- Can cause transient maternal hypotension and acidosis 6
- Serial serum potassium levels should be obtained during infusion, as isoxsuprine causes significant falls in serum potassium 5
- Maternal heart rate increases are expected due to beta-adrenergic receptor stimulation 7
Transition to Maintenance Therapy
Following IV tocolysis, the reported protocol includes:
- Intramuscular injection of 10 mg every 4 hours for the first 24 hours 2
- Followed by oral sustained-release 40 mg capsules twice daily until delivery or 37 completed weeks 2
Critical Clinical Caveat
The absence of FDA-approved IV dosing reflects the lack of standardized safety and efficacy data for intravenous administration. All IV use represents off-label practice based on historical obstetric protocols, primarily from international literature. The oral formulation remains the only FDA-approved route of administration. 1